Susquehanna Lowers RXO (NYSE:RXO) Price Target to $12.00

RXO (NYSE:RXOGet Free Report) had its target price lowered by research analysts at Susquehanna from $16.00 to $12.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “negative” rating on the stock. Susquehanna’s price target indicates a potential downside of 56.90% from the stock’s previous close.

RXO has been the topic of a number of other reports. Benchmark reaffirmed a “hold” rating on shares of RXO in a research report on Tuesday, October 15th. Jefferies Financial Group cut their target price on RXO from $33.00 to $31.00 and set a “buy” rating on the stock in a research report on Tuesday, August 13th. Morgan Stanley boosted their target price on RXO from $19.00 to $26.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $31.00 target price on shares of RXO in a research report on Monday. Finally, UBS Group boosted their target price on RXO from $22.00 to $31.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $26.29.

Check Out Our Latest Stock Analysis on RXO

RXO Stock Up 0.1 %

RXO opened at $27.84 on Tuesday. RXO has a one year low of $18.75 and a one year high of $32.82. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.33 and a current ratio of 1.33. The stock’s fifty day moving average is $27.84 and its 200-day moving average is $25.98. The company has a market capitalization of $4.48 billion, a PE ratio of -14.06, a P/E/G ratio of 13.01 and a beta of 1.33.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $956.19 million. During the same quarter in the previous year, the business earned $0.05 EPS. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. On average, equities analysts predict that RXO will post 0.14 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

A number of large investors have recently bought and sold shares of RXO. Swedbank AB bought a new stake in RXO during the 1st quarter worth approximately $76,982,000. MFN Partners Management LP grew its position in RXO by 19.8% during the 1st quarter. MFN Partners Management LP now owns 15,588,555 shares of the company’s stock worth $340,922,000 after acquiring an additional 2,580,330 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its position in RXO by 1,459.0% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 1,628,080 shares of the company’s stock worth $42,574,000 after acquiring an additional 1,523,650 shares during the last quarter. Loomis Sayles & Co. L P bought a new stake in RXO during the 3rd quarter worth approximately $27,964,000. Finally, Driehaus Capital Management LLC bought a new position in RXO in the 2nd quarter valued at $19,965,000. 92.73% of the stock is currently owned by institutional investors.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.